IP Library › Granted Patent US 11,851,447
Granted Patent B2
US 11,851,447 · App. 16/814,423 · Granted Dec 26, 2023

Dinuclear platinum(II) compounds and methods of use thereof

Inventors: Christopher Pigge (Iowa City, IA); Moustafa Tarek Ahmed Ibrahim Gabr (Iowa City, IA)
Assignee: UNIVERSITY OF IOWA RESEARCH FOUNDATION
C07F15/0086C07H21/04C12N15/11C12Q1/34G01N21/359G01N21/76C12Q1/68G01N2333/916
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,851,447
App. No.
16/814,423
Granted
Dec 26, 2023
Kind
B2
Abstract

The invention provides a compound of formula (Ia) or (Ib): or a salt thereof, wherein A, B, C, D, E, F, J, K, L, M, Q, V, X, Y, W and Z have any of the values described in the specification, as well as compositions comprising a compound of formula (Ia) or (Ib) or a salt thereof, and methods of use thereof.

Claims (49)

1. A compound of formula (Ia) or (Ib):

(SEQ ID NO: 1)

GGGGTTTTGGGGGGGTTTTGGG,

(SEQ ID NO: 2)

AGGGTTAGGGTTAGGGTTAGGG,

or

(SEQ ID NO: 3)

TGAGGGTGGGTAGGGTGGGTAA.

wherein:

A, B, C, D, E, F, J and K are aryl or heteroaryl;

L, M, Q and V are selected from the group consisting of S, O, and N; provided 2 and only 2 of the 4 are nitrogen;

X, Y, W and Z are selected from the group consisting of S, O, and N; provided 2 and only 2 of the 4 are nitrogen;

wherein CWXAEQLJ is a mirror image of DZYBFVMK and CWXAE is a mirror image of DZYBF;

or a salt thereof.

2. The compound or salt of claim 1 , wherein C, D, J and K are each benzothiazolyl.

3. The compound or salt of claim 1 , wherein A, B, E and F are each pyridyl.

4. The compound or salt of claim 1 , which is a compound of formula (Ia), wherein A and B, or C and D, or E and F, or J and K, or A and D, or B and C, or J and F, or E and K are each phenyl.

5. The compound or salt of claim 2 , which is a compound of formula (Ib), wherein E and F are each phenyl, anthracenyl, pyrenyl, or naphthyl.

6. The compound or salt of claim 1 , which is a compound of formula (Ia), wherein L and M, or Q and V, or L and V, or Q and M are each carbon.

7. The compound or salt of claim 1 , which is a compound of formula (Ia), wherein L and M, or Q and V, or L and V, or Q and M are each a heteroatom.

8. The compound or salt of claim 7 , which is a compound of formula (Ia), wherein L and M, or Q and V, or L and V, or Q and M are each nitrogen.

9. The compound or salt of claim 1 , wherein X and Y, or W and Z, or X and Z, or W and Y are each nitrogen.

10. The compound or salt of claim 1 , wherein X and Y, or W and Z, or X and Z, or W and Y are each carbon.

11. A compound selected from a group consisting of:

or a salt thereof.

12. A composition comprising 1) a plurality of compounds of formula (Ia), (Ib) or salts thereof as described claim 1 ; and 2) at least one DNA oligonucleotide.

13. The composition of claim 12 , wherein the at least one DNA oligonucleotide comprises a sequence having at least 80% sequence identity to: GGGGTTTTGGGGGGGTTTTGGG (SEQ ID NO:1), AGGGTTAGGGTTAGGGTTAGGG (SEQ ID NO:2), or TGAGGGTGGGTAGGGTGGGTAA (SEQ ID NO:3).

14. The composition of claim 12 , wherein the at least one DNA oligonucleotide comprises a sequence TGAGGGTGGGTAGGGTGGGTAA (SEQ ID NO:3).

15. A method of detecting the presence of DNAse I in a test sample, the method comprising:

1) contacting a composition as described in claim 12 with the test sample to provide a first reaction mixture; and

2) measuring the NIR emission intensity of the first reaction mixture, wherein an increase in the NIR emission intensity as compared to a control correlates with the presence of DNAse I in the test sample.

16. A method of detecting the presence of DNAse I in a test sample, the method comprising:

1) measuring the NIR emission intensity of a composition as described in claim 12 ;

2) contacting the composition with the test sample to provide a first reaction mixture; and

3) measuring the NIR emission intensity of the first reaction mixture, wherein an increase in the NIR emission of the first reaction mixture as compared to the NIR emission intensity of the composition correlates with the presence of DNAse I in the test sample.

17. A method of identifying a DNAse I inhibitor, the method comprising:

1) contacting a composition as described in claim 12 , DNAse I and a test compound to provide a first reaction mixture;

2) measuring the NIR emission intensity of the first reaction mixture; and

3) identifying the test compound as a DNAse I inhibitor when a decrease in the NIR emission intensity is detected as compared to a control.

18. A method of identifying a DNAse I inhibitor, the method comprising:

1) contacting a composition as described in claim 12 and DNAse I to provide a first reaction mixture;

2) measuring the NIR emission intensity of the first reaction mixture;

3) contacting a composition as described in any one of claims 14 , DNAse I and the test compound to provide a second reaction mixture;

4) Measuring the NIR emission intensity of the second reaction mixture; and

5) identifying the test compound as a DNAse I inhibitor when the NIR emission intensity of the second reaction mixture is less than the NIR emission intensity of the first reaction mixture.

19. A kit comprising:

1) a plurality of compounds of formula (Ia), (Ib) or salts thereof as described in claim 1 ;

2) G-quadruplex DNA; and

3) instructions for detecting the presence of DNAse I in a test sample or identifying a DNAse I inhibitor, using the plurality of compounds of formula (Ia), (Ib) or salts thereof, and the G-quadruplex DNA.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 2, 2020
From: PIGGE, CHRISTOPHER; GABR, MOUSTAFA TAREK AHMED IBRAHAM
To: UNIVERSITY OF IOWA RESEARCH FOUNDATION
Reel/Frame 053676/0869 →
Continuity (2)
Provisional Application 62816421 · Mar 11, 2019
Related Publication 20200308208A1 · Oct 1, 2020